Detection of oestrogen receptor variants in endometrium, myometrium, leiomyoma and peripheral blood mononuclear cells: Comparison to variants present in breast cancer

Journal of Cancer Research and Clinical Oncology

Volumn 124, Issue 9, 1998, Pages 478-484

  Moutsatsou, P ^a   Kassi, E ^a   Creatsas, G ^b   Coulocheri, S ^a   Scheller, K ^c   Sekeris, C E ^a,d  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d INSTITUTE OF BIOLOGY   (Greece)

Author keywords

Breast cancer; Leiomyoma; Myometrium; Oestrogen receptor; Variant

Indexed keywords

ESTROGEN RECEPTOR;

ALTERNATIVE RNA SPLICING; ARTICLE; BREAST CANCER; CONTROLLED STUDY; ENDOMETRIUM; EXON; FEMALE; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEIOMYOMA; MONONUCLEAR CELL; MYOMETRIUM; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; UTERUS MYOMA;

BASE SEQUENCE; BREAST NEOPLASMS; DNA PRIMERS; ENDOMETRIUM; FEMALE; HUMANS; LEIOMYOMA; LEUKOCYTES, MONONUCLEAR; MOLECULAR SEQUENCE DATA; MYOMETRIUM; POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN; RNA-DIRECTED DNA POLYMERASE; SEQUENCE ANALYSIS, DNA; UTERINE NEOPLASMS;

EID: 0031710632     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050202     Document Type: Article

References (40)

1. Beato M (1989) Gene regulation by steroid hormones. Cell 56:335-344
2. Beato M, Herrlich P, Schutz G (1995) Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857
3. Bunone G, Briand PA, Miksicek RJ, Picard D (1996) Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 15:2174-2183
4. Chaidarun SS, Klibanski A, Alexander JM (1997) Tumor-specific expression of alternatively spliced estrogen receptor messenger rihonucleic acid variants in human pituitary adenomas. J Clin Endocrinol Metab 82:1058-1065
5. Encarnacion CA, Fuqua SAW (1993) Estrogen receptor variants in breast cancer. In: Moudgil V.K. (ed) Steroid hormone receptors. Birkhauser, Boston, Mass, pp 427-444
6. Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240:889-895
7. Faye JC, Fargin A, Bayard F (1986) Dissimilarities between the uterine oestrogen receptor in cytosol of castrated and oestradiol treated rats. Endocrinology 118:2276-2283
8. Fuqua SA, Fitzgerald SD, Chamness GC, Tandon AK, McDonell DP, Nowaz Z, O'Malley BW, McGuire WC (1991) Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res 51:105-109
9. Fuqua SA, Fitzgerald SD, Allred DC, Elledge RM, Nawaz A, McDonnell DP, et al. (1992) Inhibition of estrogen receptor activity by a naturally occuring variant in human breast tumours. Cancer Res 52:483-486
10. Gotteland M, Desanty G, Delarue JC, Liu L, May E (1995) Human estrogen receptor messenger RNA variants in both normal and tumor breast tissues. Mol Cell Endocrinol 112:1-13
11. Green S, Chambon P (1991) The oestrogen receptor: from perception to mechanism. In: London, Parker MG (ed) Nuclear hormone receptors. Academic Press pp 15-38
12. Green S, Walter P, Kumar V, Krust A, Bornert J, Argos P, Chambon P (1986) Human oestrogen receptor cDNA: Sequence expression and homology to v-ezb-A. Nature 320: 134-139
13. Greene GL, Gilma P, Waterfield M, Baker A, Hort Y, Shine J (1986) Sequence and expression of human estrogen receptor complementary DNA. Science 231:1150-1154
14. Ignar-Trowbridge DM, Nelson KR, Bidwell MC, Curtis SW, Washburn TF, McLahclan JA, Korach K (1992) Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci USA 89:4658-4662
15. Joel PB, Traish AM, Lannigan DA (1995) Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. Mol Endocrinol 9:1041-1052
16. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P (1995) Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491-1494
17. Kumar V, Green S, Stack G, Bery M, Jin JR, Chambon P (1987) Functional domains of the human estroren receptor. Cell 51:941-951
18. Levy C, Robel P, Gautray JP, De Brux J, Verman U, Descomps B, Baulieu EE, Eychennes B (1980) Estradiol and progesterone receptors in human endometrium. Normal and abnormal menstrual cycles and early pregnancy. Am J Obstet Gynecol 136:646-651
19. Leygue ER, Watson PH, Murphy LC (1996a) Estrogen receptor variants in normal human mammary tissue. J Nat Cancer Inst 88:284-290
20. Leygue E, Huang A, Murphy LC, Watson PH (1996b) Prevalence of estrogen receptor variant messenger RNAs in human breast cancer. Cancer Res 56:4324-4327
21. Liggins GC (1994) Mechanisms of the onset of labor: the New Zealand perspective. Aust NZJ Obstet Gynaecol 34:338-342
22. Marsigliante S, Baker VA, Puddefoot J, Barker S, Vinson GP (1991) Oestrogen receptor isoforms and their distribution in breast cancer samples. J Mol Endocrinol 7:205-211
23. Marsigliante S, Muscella A, Ciardo V, Puddefoot JR, Leo G, Vinson GP, Storelli C (1995) Multiple isoforms of the oestrogen receptor in endometrial cancer. J Mol Endocrinol 14:365-374
24. McGuire WL, Chamness GC, Fuqua SAW (1991) Estrogen receptor variants in clinical breast cancer. Mol Endocrinol 5:1571-1577
25. Montano MM, Ekena K, Krueger KD, Keller AL, Katzenellenbogen BS (1996) Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens. Mol Endocrinol 10:230-242
26. Morel V (1995) Zeroing in on how hormones affect the immune system. Science 269:773-775
27. Moutsatsou P, Sekeris CE (1997) Estrogen and progesterone receptors in the endomelrium. Ann N Y Acad Sci 816:99-115
28. Padayachi T, Pegoraro RJ, Rom L, Joubert SM (1990) Enzyme immunoassay of oestrogen and progesterone receptors in uterine and intra-uterine tissue during human pregnancy and labor. J Steroid Biochem Mol Biol 37:509-511
29. Paech K, Webb P, Kuiper GGJM, Nilsson S, Gustafsson JA, Kushner PJ, Scanlan TS (1997) Differential ligand activation of estrogen receptors ERa and ERb at API sites. Science 277:1508-1510
30. Pennisi E (1996) Drug's link to genes reveals estrogen's many sides. Science 273:1171-1224
31. Pennisi E (1997) Differing roles found for estrogen's two receptors. Science 277:1439
32. Reu D, Parker MG (1996) Effects of an exon 5 variant of the estrogen receptor in MCF-7 breast cancer cells. Cancer Res 56:1556-1563
33. Pfeffer U, Fecarotta E, Vidali G (1995) Coexpression of multiple estrogen receptor variant messenger RNAs in normal and neoplastic breast tissues and in MCF-7 cells. Cancer Res 55:2158-2165
34. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory mannual, 2nd edn. Cold Spring Harbor, Laboratory, Cold spring Harbor, NY
35. Sluyser M (1992) Role of estrogen receptor variants in the development of hormone resistance in breast cancer. Clin Biochem 25:407-414
36. Wang Y, Miksicek RJ (1991) Identification of a dominant negative form of the human estrogen receptor. Mol Endocrinol 5:1707-1715
37. White R, Sjoberg M, Kalkhoven E, Parker MG (1997) Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine. EMBO J 16:1427-1435
38. Wilson KB, Evans M, Abdou NI (1996) Presence of a variant form of the estrogen receptor in peripheral blood mononuclear cells from normal individuals and lupus patients. J Reprod Immunol 31:199-208
39. Woolley DE, Hope WG, Thompson-Recce MA, Gietzen DW, Conway SB (1994) Dopaminergie stimulation of estrogen receptor binding in vivo: a reexammation. Rec Proa Horm Res 49:383-392
40. Zhuang Y, Katzenellenbogen BS, Shapiro DJ (1995) Estrogen receptor mutatns which do not bind 17β-estradiol dimerize and bind to the estrogen response element in vivo. Mol Endocrinol 9:457-460